Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 19/20 | 1.00 |
| ▸ | TBXA2R | P21731 | 4/20 | 1.00 |
| ▸ | PTGIS | Q16647 | 11/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9262311 | 0.93 | TBXAS1 (0.87) | TBXAS1TBXA2RPTGIS | |
| SCHEMBL9267358 | 0.93 | TBXAS1 (0.87) | TBXAS1TBXA2RPTGIS | |
| SCHEMBL9459521 | 0.93 | TBXAS1 (0.87) | TBXAS1TBXA2RPTGIS | |
| SCHEMBL9765855 | 0.87 | TBXAS1 (1.00) | TBXAS1TBXA2RPTGIS | |
| SCHEMBL9765856 | 0.87 | TBXAS1 (1.00) | TBXAS1TBXA2RPTGIS | |
| SCHEMBL3518907 | 0.73 | TBXAS1 (1.00) | TBXAS1TBXA2RPTGIS | |
| SCHEMBL9035683 | 0.73 | TBXAS1 (1.00) | TBXAS1TBXA2RPTGIS | |
| SCHEMBL3518900 | 0.73 | TBXAS1 (1.00) | TBXAS1TBXA2RPTGIS | |
| SCHEMBL9765895 | 0.70 | TBXAS1 (0.85) | TBXAS1TBXA2RPTGIS | |
| SCHEMBL9765884 | 0.70 | TBXAS1 (1.00) | TBXAS1PTGIS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5410064-A | Thromboxane A2 antagonists and inhibitors of thromboxane A2 synthase | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1995-04-25 | — | — | US | disclosed |
| US-5219874-A | Heterocyclic acids | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-06-15 | — | — | US | disclosed |
| EP-0482771-A2 | Heterocyclic acids | ZENECA LIMITED (GB) | 1992-04-29 | — | — | EP | disclosed |